{
    "zip": "46285",
    "sector": "Healthcare",
    "fullTimeEmployees": 33625,
    "longBusinessSummary": "Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; and Avidity Biosciences, Inc. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.",
    "city": "Indianapolis",
    "phone": "317 276 2000",
    "state": "IN",
    "country": "United States",
    "companyOfficers": [],
    "website": "http://www.lilly.com",
    "maxAge": 1,
    "address1": "Lilly Corporate Center",
    "industry": "Drug Manufacturers\u2014General",
    "previousClose": 130.31,
    "regularMarketOpen": 133.03,
    "twoHundredDayAverage": 122.32788,
    "trailingAnnualDividendYield": 0.01979894,
    "payoutRatio": 0.5202,
    "volume24Hr": null,
    "regularMarketDayHigh": 140.86,
    "navPrice": null,
    "averageDailyVolume10Day": 5571662,
    "totalAssets": null,
    "regularMarketPreviousClose": 130.31,
    "fiftyDayAverage": 139.94647,
    "trailingAnnualDividendRate": 2.58,
    "open": 133.03,
    "averageVolume10days": 5571662,
    "expireDate": null,
    "yield": null,
    "algorithm": null,
    "dividendRate": 2.96,
    "exDividendDate": 1581552000,
    "beta": 0.244699,
    "circulatingSupply": null,
    "startDate": null,
    "regularMarketDayLow": 133,
    "priceHint": 2,
    "currency": "USD",
    "trailingPE": 15.78545,
    "regularMarketVolume": 5172035,
    "lastMarket": null,
    "maxSupply": null,
    "openInterest": null,
    "marketCap": 134256910336,
    "volumeAllCurrencies": null,
    "strikePrice": null,
    "averageVolume": 3820131,
    "priceToSalesTrailing12Months": 6.0152297,
    "dayLow": 133,
    "ask": 0,
    "ytdReturn": null,
    "askSize": 900,
    "volume": 5172035,
    "fiftyTwoWeekHigh": 147.87,
    "forwardPE": 18.254877,
    "fromCurrency": null,
    "fiveYearAvgDividendYield": 2.4,
    "fiftyTwoWeekLow": 101.36,
    "bid": 0,
    "tradeable": true,
    "dividendYield": 0.0227,
    "bidSize": 900,
    "dayHigh": 140.86,
    "exchange": "NYQ",
    "shortName": "Eli Lilly and Company",
    "longName": "Eli Lilly and Company",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EST",
    "isEsgPopulated": false,
    "gmtOffSetMilliseconds": "-18000000",
    "quoteType": "EQUITY",
    "symbol": "LLY",
    "messageBoardId": "finmb_285467",
    "market": "us_market",
    "annualHoldingsTurnover": null,
    "enterpriseToRevenue": 5.902,
    "beta3Year": null,
    "profitMargins": 0.3727,
    "enterpriseToEbitda": 18.216,
    "52WeekChange": 0.028654814,
    "morningStarRiskRating": null,
    "forwardEps": 7.69,
    "revenueQuarterlyGrowth": null,
    "sharesOutstanding": 960131008,
    "fundInceptionDate": null,
    "annualReportExpenseRatio": null,
    "bookValue": 2.873,
    "sharesShort": 12248540,
    "sharesPercentSharesOut": 0.0128,
    "fundFamily": null,
    "lastFiscalYearEnd": 1577750400,
    "heldPercentInstitutions": 0.81463,
    "netIncomeToCommon": 4637899776,
    "trailingEps": 8.893,
    "lastDividendValue": null,
    "SandP52WeekChange": 0.08368194,
    "priceToBook": 48.86182,
    "heldPercentInsiders": 0.00204,
    "nextFiscalYearEnd": 1640908800,
    "mostRecentQuarter": 1577750400,
    "shortRatio": 3.32,
    "sharesShortPreviousMonthDate": 1579046400,
    "floatShares": 790066175,
    "enterpriseValue": 131737165824,
    "threeYearAverageReturn": null,
    "lastSplitDate": 876960000,
    "lastSplitFactor": "2:1",
    "legalType": null,
    "morningStarOverallRating": null,
    "earningsQuarterlyGrowth": 0.33,
    "dateShortInterest": 1581638400,
    "pegRatio": 1.66,
    "lastCapGain": null,
    "shortPercentOfFloat": 0.0134000005,
    "sharesShortPriorMonth": 12983489,
    "category": null,
    "fiveYearAverageReturn": null,
    "regularMarketPrice": 133.03,
    "logo_url": "https://logo.clearbit.com/lilly.com"
}